ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform legislation with respect to pharmacy issues and the professional role of pharmacists; increased federal funding for comparative effectiveness research; establishment of a public-private entity to coordinate comparative effectiveness research; legislation relating to health information technology and electronic prescribing; appropriations for U.S. Food and Drug Administration and the Agency for Healthcare Research and Quality.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Medicare/Medicaid MMM
Proposed changes to the Medicare Part D prescription drug benefit. Adjustment to Medicaid prescription drug reimbursement rates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Labor Issues/Antitrust/Workplace LBR
Legislation that would grant independent pharmacists collective bargaining rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Pharmacy PHA
Health care reform legislation with respect to pharmacy issues and the professional role of pharmacists; legislation related to medication therapy management programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.